# Effect of Adding Simethicone to Split-dose Polyethylene Glycol for Bowel Preparation in a Screening Colonoscopy Setting

> **NCT03816774** · NA · COMPLETED · sponsor: **Portuguese Oncology Institute, Coimbra** · enrollment: 412 (actual)

## Conditions studied

- Colo-rectal Cancer
- Colonic Neoplasms

## Interventions

- **DRUG:** PEG split-dose and simethicone

## Key facts

- **NCT ID:** NCT03816774
- **Lead sponsor:** Portuguese Oncology Institute, Coimbra
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-15
- **Primary completion:** 2022-09-17
- **Final completion:** 2022-09-17
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2022-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03816774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03816774, "Effect of Adding Simethicone to Split-dose Polyethylene Glycol for Bowel Preparation in a Screening Colonoscopy Setting". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03816774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*